Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Active
-
FWOSB161: FORX - FOod interventions to Reduce immunotherapy toXicity
1/11/23 → 31/10/27
Project: Fundamental
-
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)
Mac Eochagain, C., Neuendorff, N. R., Gente, K., Leipe, J., Verhaert, M., Sam, C., de Glas, N., Kadambi, S., Canin, B., Gomes, F., Decoster, L., Korc-Grodzicki, B., Rostoft, S., Battisti, N. M. L. & Wildiers, H., 4 Feb 2025, In: Lancet Oncology. 26, 2, p. e90-e102 13 p.Research output: Contribution to journal › Article › peer-review
-
Three-year analysis of the Belgian multidisciplinary immunotoxicity (BITOX) board: organization, feasibility, and results
Verhaert, M., Aydogan, Y. & Aspeslagh, S., 28 Apr 2025, In: ESMO Real World Data and Digital Oncology. 8, p. 1-6 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Trial in Progress (TiP): The FOod intervention trial to Reduce immunotherapy toXicity (FORX)
Aspeslagh, S., Demol, J., Demuyser, T., Adriaenssens, N. & Verhaert, M., 2025. 1 p.Research output: Unpublished contribution to conference › Poster
-
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
Verheijden, R. J., Burgers, F. H., Janssen, J. C., Putker, A. E., Veenstra, S. P. G. R., Hospers, G. A. P., Aarts, M. J. B., Hehenkamp, K. W., Doornebosch, V. L. E., Verhaert, M., van den Berkmortel, F. W. P. J., Chatzidionysiou, K., Llobell, A., Barros, M., Maria, A. T. J., Takeji, A., García Morillo, J-S., Lidar, M., van Eijs, M. J. M., Blank, C. U., & 9 others , Aug 2024, In: European Journal of Cancer. 207, 6 p., 114172.Research output: Contribution to journal › Article › peer-review
Open AccessFile15 Citations (Scopus)5 Downloads (Pure) -
HCC Podcast Expert Series: Wat beïnvloedt, positief of negatief, het effect van immunotherapie?
Verhaert, M., 21 Apr 2024Research output: Non-textual form › Digital or Visual Products
Prizes
-
First price - Best oral presentation of a junior clinical abstract at BSMO
Verhaert, Marthe (Recipient), 1 Feb 2025
Prize: Prize (including medals and awards)
-
FWO Travel grant to SITC conference
Verhaert, Marthe (Recipient), Oct 2023
Prize: Prize (including medals and awards)
Activities
-
Journal club - intratumoraal microbioom
Marthe Verhaert (Speaker)
24 Jan 2025Activity: Talk or presentation › Talk at a school event
-
Cardio-Oncology case
Marthe Verhaert (Speaker)
6 Feb 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Is immunotherapy an option in patients treated with immunosuppressive medication?
Marthe Verhaert (Speaker)
20 Feb 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Efficacy and safety of ICI in patients taking immunosuppressive medication
Marthe Verhaert (Speaker)
16 Jan 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Three-year experience of the BITOX board
Marthe Verhaert (Speaker)
30 Jan 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
Press/Media
-
Delhaize Lunch & Learn: FORX-project
18/03/25
1 Media contribution
Press/Media: Public Engagement Activities
-
-
Podcast Host Je Levensstijl als medicijn
Len De Nys, Andreas Delaere, Marthe Verhaert, Luc Colemont, Marie Beatrice D'Hooghe, Steven Laureys, Christel Fontaine & Julie Vanderlinden
19/03/21 → 5/03/25
16 Media contributions
Press/Media: Public Engagement Activities
-
LifeMe podcast: Immuuntherapie en Darmgezondheid: Hoe Voeding de Behandeling van Kanker Beïnvloedt
9/11/24
1 Media contribution
Press/Media: Public Engagement Activities
-
Thesis
-
3-YEAR ANALYSIS OF THE BELGIAN MULTIDISCIPLINARY IMMUNOTOXICITY (BITOX) BOARD
Author: Aydogan, Y., Verhaert, M. & Aspeslagh, S., 10 Jun 2024Student thesis: Master's Thesis
-
Pharmacological adaptations to immunosuppressive therapy in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors
Author: Cappelle, C. A., Wuyts, S., Verhaert, M., Cortoos, P. & Aspeslagh, S., 2022Student thesis: Master-after-master